FR2873294B1 - ASSOCIATION OF DRUGS - Google Patents

ASSOCIATION OF DRUGS

Info

Publication number
FR2873294B1
FR2873294B1 FR0408257A FR0408257A FR2873294B1 FR 2873294 B1 FR2873294 B1 FR 2873294B1 FR 0408257 A FR0408257 A FR 0408257A FR 0408257 A FR0408257 A FR 0408257A FR 2873294 B1 FR2873294 B1 FR 2873294B1
Authority
FR
France
Prior art keywords
drugs
association
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0408257A
Other languages
French (fr)
Other versions
FR2873294A1 (en
Inventor
Philippe Bernard
Fabrice Trovero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greenpharma SAS
Original Assignee
Greenpharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0408257A priority Critical patent/FR2873294B1/en
Application filed by Greenpharma SAS filed Critical Greenpharma SAS
Priority to EP05793762A priority patent/EP1773306A1/en
Priority to JP2007523117A priority patent/JP2008507577A/en
Priority to CNA2005800293340A priority patent/CN101014325A/en
Priority to CA002575848A priority patent/CA2575848A1/en
Priority to US11/658,643 priority patent/US20080194631A1/en
Priority to PCT/FR2005/001942 priority patent/WO2006018538A1/en
Publication of FR2873294A1 publication Critical patent/FR2873294A1/en
Application granted granted Critical
Publication of FR2873294B1 publication Critical patent/FR2873294B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
FR0408257A 2004-07-26 2004-07-26 ASSOCIATION OF DRUGS Active FR2873294B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0408257A FR2873294B1 (en) 2004-07-26 2004-07-26 ASSOCIATION OF DRUGS
JP2007523117A JP2008507577A (en) 2004-07-26 2005-07-26 Medicaments for treating disorders of the central nervous system
CNA2005800293340A CN101014325A (en) 2004-07-26 2005-07-26 Medicament for the treatment of central nervous system disorders
CA002575848A CA2575848A1 (en) 2004-07-26 2005-07-26 Medicament for the treatment of central nervous system disorders
EP05793762A EP1773306A1 (en) 2004-07-26 2005-07-26 Medicament for the treatment of central nervous system disorders
US11/658,643 US20080194631A1 (en) 2004-07-26 2005-07-26 Medicament For the Treatment of Central Nervous System Disorders
PCT/FR2005/001942 WO2006018538A1 (en) 2004-07-26 2005-07-26 Medicament for the treatment of central nervous system disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408257A FR2873294B1 (en) 2004-07-26 2004-07-26 ASSOCIATION OF DRUGS

Publications (2)

Publication Number Publication Date
FR2873294A1 FR2873294A1 (en) 2006-01-27
FR2873294B1 true FR2873294B1 (en) 2008-05-09

Family

ID=34950699

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0408257A Active FR2873294B1 (en) 2004-07-26 2004-07-26 ASSOCIATION OF DRUGS

Country Status (7)

Country Link
US (1) US20080194631A1 (en)
EP (1) EP1773306A1 (en)
JP (1) JP2008507577A (en)
CN (1) CN101014325A (en)
CA (1) CA2575848A1 (en)
FR (1) FR2873294B1 (en)
WO (1) WO2006018538A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005026386D1 (en) 2004-06-28 2011-03-31 Univ Western Australia ANTISENSE OLIGONUCLEOTIDES FOR THE INDUCTION OF EXON-SKIPPING AND METHOD OF USE THEREOF
WO2009058261A1 (en) * 2007-10-31 2009-05-07 Merck & Co., Inc. Modulation of sleep with nr2b receptor antagonists
JP5723600B2 (en) 2008-02-29 2015-05-27 ブイエム ディスカバリー インコーポレイテッド Treatment of pain syndrome and other disorders
RS58079B1 (en) 2009-11-12 2019-02-28 Univ Western Australia Antisense molecules and methods for treating pathologies
FR2954699B1 (en) * 2009-12-30 2012-01-20 Greenpharma Sas PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL DEPENDENCE
US10583138B2 (en) 2012-07-12 2020-03-10 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
US9737531B2 (en) * 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
FR2976807B1 (en) * 2011-06-24 2013-07-05 Greenpharma Sas PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DEPENDENCE IN HUMAN BEINGS
CN105378081B (en) 2013-03-14 2019-06-14 萨勒普塔医疗公司 For treating the exon skipping composition of muscular dystrophy
KR101858055B1 (en) * 2015-08-04 2018-05-15 아스테라스 세이야쿠 가부시키가이샤 Composition for ameliorating cognitive functions comprising tamsulosin
CN109890371A (en) * 2016-08-26 2019-06-14 斯瑞尼瓦萨饶·韦帕切杜 Composition and its method
KR20200046525A (en) * 2018-10-24 2020-05-07 건국대학교 글로컬산학협력단 Composition comprising pirenperone compound for treating fragile x syndrome and related developmental disorders
CN115844898A (en) * 2022-12-02 2023-03-28 浙江工业大学 Application of bunazosin in preparation of medicine for preventing or treating alcohol use disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
CN1210726A (en) * 1997-09-08 1999-03-17 郑万伦 Drugging stopping medicine for quick giving-up drugging
CA2460777A1 (en) * 2001-09-26 2003-04-03 Mitsubishi Pharma Corporation Thrombus/thrombogenesis inhibitors

Also Published As

Publication number Publication date
CN101014325A (en) 2007-08-08
JP2008507577A (en) 2008-03-13
US20080194631A1 (en) 2008-08-14
WO2006018538A1 (en) 2006-02-23
FR2873294A1 (en) 2006-01-27
EP1773306A1 (en) 2007-04-18
CA2575848A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
FR2867064B1 (en) DRUG DOSER
DE602005026188D1 (en) drug dispenser
CY2017048I2 (en) NEW PHARMACEUTICAL USES OF STAVROSPORINE DERIVATIVES
PT1957073E (en) Medicinal drug
DK2073795T3 (en) Abuse-safe drug formulation
CY2018005I1 (en) ORAL PHARMACEUTICAL FORMS OF CLANTRIVINE
MA28489B1 (en) PHARMACEUTICAL PREPARATIONS
BRPI0511900A (en) pharmaceutical compositions
DK2343071T3 (en) Pharmaceutical dosage forms
DK1757293T3 (en) BH4-RESPONSIVE HYPERPHENYLALANINARY MEDICINES
BRPI0719394A2 (en) Solid medicinal preparation
FR2873294B1 (en) ASSOCIATION OF DRUGS
DE602005017643D1 (en) DRUG ENVER Dunster
NO20034952D0 (en) Pharmaceutical compounds
ITMI20041447A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GABAPENTINA
ITMI20040943A1 (en) PHARMACEUTICAL COMPOSITION CICATRIZZANTE
ITRM20030053A1 (en) ASSOCIATION OF ANTIABETIC DRUGS.
DE112004001429D2 (en) Pharmaceutical agent
SE0400990D0 (en) Drug
FI20040558A0 (en) Pharmaceutical preparation
UA10054S (en) PACKAGING OF THE PHARMACEUTICAL
UA10038S (en) PACKAGING OF THE PHARMACEUTICAL
UA10843S (en) PACKAGING OF THE PHARMACEUTICAL
UA10535S (en) PACKAGING OF THE PHARMACEUTICAL
UA10046S (en) PHARMACEUTICAL MEDICINE PICTOGRAM

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20